CELLOP

Seoul, South Korea

Small Machines Co., Ltd. is a biotechnology company based on the development of advanced on-site in vitro diagnostics and medical devices, merged by a digital healthcare platform. The innovations that Small Machines brings are built on the foundations of the convergence of NT, IT, and BT technologies. A pioneer in the field of POCT that owns the technology to develop and manufacture the world's best microfluid chips SmallMachines possesses a key piece of Bio-MEMS technology that seamlessly integrates biotechnology with Micro-electro Mechanical Systems(MEMS), which is heralded as the most advanced technology in the 21st century. To realize this technology, SmallMachines operation encompasses R D, production, and sales of life-science lab equipment, in vitro diagnostic medical devices, and related consumables and solutions. Our company has about 100 patents related to NT-IT-BT (nanotechnology-information technology- biotechnology) convergence technology in Korea and abroad. In particular, we possess the technology for a key platform called lab-on-a-chip, which integrates laboratory processes on a meticulously designed microfluid chip, making significant contributions to the fields of medical and life science engineering. What we bring to the table our mission Smallmachines is focused on Open Innovation. We have began our journey with our core Bio-MEMS technology and have progressed on to analytical equipments: CELLOP, DELISA, and WHOPE. Furthermore, we have developed a CDSS Platform for early diagnosis of diseases and personalized healthcare facilitated through the data gathered by our equipment. SmallMachines brings a comprehensive and unique solution to modern day healthcare by providing both innovative hardware and software for the mission of affordable, universal healthcare.